ZA200004387B - Anti-tumour agents. - Google Patents

Anti-tumour agents.

Info

Publication number
ZA200004387B
ZA200004387B ZA200004387A ZA200004387A ZA200004387B ZA 200004387 B ZA200004387 B ZA 200004387B ZA 200004387 A ZA200004387 A ZA 200004387A ZA 200004387 A ZA200004387 A ZA 200004387A ZA 200004387 B ZA200004387 B ZA 200004387B
Authority
ZA
South Africa
Prior art keywords
alkyl
hydrogen
tumour agents
akanesulphonyloxy
alkanesulphonyloxy
Prior art date
Application number
ZA200004387A
Other languages
English (en)
Inventor
Francis Thomas Boyle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200004387B publication Critical patent/ZA200004387B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/34—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
ZA200004387A 1998-03-20 2000-08-24 Anti-tumour agents. ZA200004387B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9805866.2A GB9805866D0 (en) 1998-03-20 1998-03-20 Anti-tumour agents

Publications (1)

Publication Number Publication Date
ZA200004387B true ZA200004387B (en) 2001-10-31

Family

ID=10828858

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004387A ZA200004387B (en) 1998-03-20 2000-08-24 Anti-tumour agents.

Country Status (18)

Country Link
US (1) US6346633B1 (de)
EP (1) EP1064253B1 (de)
JP (1) JP2002507590A (de)
KR (1) KR20010042055A (de)
CN (1) CN1293654A (de)
AT (1) ATE231835T1 (de)
AU (1) AU756651B2 (de)
BR (1) BR9908932A (de)
CA (1) CA2324361A1 (de)
DE (1) DE69905142T2 (de)
DK (1) DK1064253T3 (de)
ES (1) ES2190199T3 (de)
GB (1) GB9805866D0 (de)
IL (1) IL138589A (de)
NO (1) NO20004662L (de)
NZ (1) NZ505856A (de)
WO (1) WO1999048857A1 (de)
ZA (1) ZA200004387B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805868D0 (en) 1998-03-20 1998-05-13 Zeneca Ltd Anti-tumour agents
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
AU2017291411A1 (en) * 2016-06-27 2019-01-03 Systems Oncology, Llc Combination chemotherapies
WO2020210831A1 (en) * 2019-04-12 2020-10-15 TONIX Pharmaceuticals Holding Corp Inhibitors of cd40-cd154 binding

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
JPS58177934A (ja) 1982-04-13 1983-10-18 Takeda Chem Ind Ltd ベンゾキノン誘導体
NZ240785A (en) * 1991-11-28 1995-08-28 Cancer Res Campaign Tech Substituted nitro aniline derivatives and medicaments
GB9805868D0 (en) 1998-03-20 1998-05-13 Zeneca Ltd Anti-tumour agents

Also Published As

Publication number Publication date
NZ505856A (en) 2002-09-27
DK1064253T3 (da) 2003-06-23
BR9908932A (pt) 2005-10-25
DE69905142D1 (de) 2003-03-06
AU756651B2 (en) 2003-01-16
DE69905142T2 (de) 2003-10-16
EP1064253B1 (de) 2003-01-29
EP1064253A1 (de) 2001-01-03
CN1293654A (zh) 2001-05-02
AU2846899A (en) 1999-10-18
IL138589A0 (en) 2001-10-31
US6346633B1 (en) 2002-02-12
IL138589A (en) 2004-08-31
GB9805866D0 (en) 1998-05-13
KR20010042055A (ko) 2001-05-25
WO1999048857A1 (en) 1999-09-30
NO20004662D0 (no) 2000-09-19
JP2002507590A (ja) 2002-03-12
NO20004662L (no) 2000-11-17
CA2324361A1 (en) 1999-09-30
ATE231835T1 (de) 2003-02-15
ES2190199T3 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
DE60112609D1 (en) Pyrazolopyridine
PL337329A1 (en) Oxazolydinone based antibacterial agents comprising a thiocarbonyl functional group
TW282456B (de)
AU7700096A (en) Novel 2,3,5-trimethyl-4-hydroxyanilide derivatives, their preparation and their application in therapeutics
TR200103683T2 (tr) Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı
RS50829B (sr) Novi oligosaharidi, njihova proizvodnja i farmaceutske kompozicije sa sadržajem istih
IL138590A0 (en) Anti-tumour agents
HUP0002951A2 (hu) Proteáz inhibitor hatású Disz(amino-metil)-keton-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
IL138589A0 (en) Anti-tumour agents
GB9824207D0 (en) Neurological disorders
TNSN06142A1 (en) Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
MXPA02012426A (es) Compuestos nuevos.
IL150605A0 (en) Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
ZA995321B (en) Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.
MXPA04005151A (es) Compuestos terapeuticos.
NZ310385A (en) Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
YU23498A (sh) Herbicidni 3,5-difluoropiridini
TW200505338A (en) Pyrazole compound
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.
TW370460B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...